Overview

Efficacy of Lidocaine Versus Placebo in Palliative Care Patients With Opioid-refractory Cancer Pain With Neuropathic Component: a Multicenter, Prospective, Double-blind Randomized Placebo-controlled Study.

Status:
Unknown status

Trial end date:
2016-09-01

Target enrollment:

Participant gender:

Summary

This is a multicenter, prospective, randomized, placebo-controlled, double-blind, two-parallel groups study comparing lidocaine (experimental group) to placebo (control group). The study protocol was elaborated using the recommendations of the Consolidated Standards of Reporting Trials (CONSORT) Statement.

Phase:

Phase 3

Details

Lead Sponsor:

Assistance Publique Hopitaux De Marseille

Treatments:

Lidocaine